Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N.V. COM | 4,778,581 | 4,778,581 | 0 | $132.61M | $134.99M | 56.94% | +$2.39M |
| Cytokinetics, Incorporated(CYTK) | 458,295 | 503,295 | +45,000 | $29.12M | $33.17M | 13.99% | +$4.05M |
| Eikon Therapeutics, Inc.(EIKN) | 0 | 1,943,682 | +1,943,682 | $0 | $20.56M | 8.67% | +$20.56M |
| Lyell Immunopharma, Inc.(LYEL) | 800,399 | 800,399 | 0 | $24.64M | $16.06M | 6.77% | -$8.58M |
| Relay Therapeutics, Inc.(RLAY) | 1,000,000 | 1,000,000 | 0 | $8.46M | $9.95M | 4.20% | +$1.49M |
| Xenon Pharmaceuticals Inc.(XENE) | 160,000 | 160,000 | 0 | $7.17M | $9.30M | 3.92% | +$2.13M |
| Alector, Inc. | 3,887,200 | 3,887,200 | 0 | $6.06M | $8.36M | 3.53% | +$2.29M |
| Maze Therapeutics, Inc.(MAZE) | 522,657 | 156,901 | -365,756 | $21.65M | $4.68M | 1.98% | -$16.97M |